100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothGliclazide 80mg + Metformin 500mg + Voglibose 0.2mg
You Searched
Our Recommendation
Gliclize MV 0.2mg Tablet 10s
Johnlee Pharmaceuticals Pvt. Ltd.
8+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Customers also bought
More About Glictrio MV 0.2mg/500mg/80mg Tablet
Side Effects
Side effects of Glictrio MV Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Glictrio MVNausea Hypoglycemia (low blood glucose level)Abdominal pain Constipation
How to use
How to use Glictrio MV Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Glictrio MV 0.2mg/500mg/80mg Tablet is to be taken with food.
How it works
How Glictrio MV Tablet works Glictrio MV 0.2mg/500mg/80mg Tablet is a combination of three antidiabetic medicines:.
Unsafe: Avoid consuming alcohol with Glictrio MV 0.2mg/500mg/80mg Tablet as it is deemed unsafe.
Glictrio MV 0.2mg/500mg/80mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Glictrio MV 0.2mg/500mg/80mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Glictrio MV 0.2mg/500mg/80mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glictrio MV 0.2mg/500mg/80mg Tablet may be needed. Doctor consultation is advised.Use of Glictrio MV 0.2mg/500mg/80mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Glictrio MV 0.2mg/500mg/80mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glictrio MV 0.2mg/500mg/80mg Tablet may be needed. Doctor consultation is advised.Glictrio MV 0.2mg/500mg/80mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Manufacturer Address
C 817 SIDDHI VINAYAK TOWER C OPP S G HIGHWAY MAKARBA AHMEDABAD Ahmedabad GJ 380051 IN
References
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)
Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003 (12 Mar. 2019)
Gliclazide+Metformin+Voglibose (21 Oct. 2021)
American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S98-S110 (21 Oct. 2021)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
